Skip to content
Screener

Integra LifeSciences IART Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$4.48M+101%-$4.62M+81.7%-$1.7M-$5.4M+49.5%-$484.07M-3,803%
$38.14M+1.2%$38.43M+3.3%$38.43M+2.2%$38.52M+7.1%$37.69M+2.5%
$5.84M+10.4%$5.17M+176%$5.84M-18.4%$5.58M+27.3%$5.3M-26.9%
$22.8M+156%$9.8M+187%$11.82M-76.7%$40.91M+81.9%$8.92M-77.9%
$12.31M-38.9%$14.85M-48.7%$17.21M-41.8%$15.16M-48.9%$20.15M-32.2%
-$43.28M-99.9%-$14.85M+58.7%-$34.91M-722%-$15.59M-49.9%-$21.65M+93.3%
$55.25K-97.8%$55.25K$55.25K-99.9%
$8.3M-76.5%$24.34M
-$22.39M-5.7%$1.76M+124%-$21.19M+94.4%
$10.5M+193%-$5.05M+87.4%-$5.4M-126%-$11.23M-205%

FAQ

How much cash does Integra LifeSciences generate?
Integra LifeSciences (IART) generated $85.3M in operating cash flow over the trailing twelve months.
What is Integra LifeSciences's free cash flow?
After $59.5M of capital expenditures, Integra LifeSciences's free cash flow was -$11.2M over the trailing twelve months, down 38.8% year over year.
Where does Integra LifeSciences's cash flow data come from?
Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.